Efficacy of methylene blue monotherapy in semi-immune adults with uncomplicated falciparum malaria: A controlled trial in Burkina Faso

Tropical Medicine and International Health

Volumn 15, Issue 6, 2010, Pages 713-717

  Bountogo, Mamadou ^a   Zoungrana, Augustin ^a   Coulibaly, Boubacar ^a   Klose, Christina ^b   Mansmann, Ulrich ^c   Mockenhaupt, Frank P ^d   Burhenne, Jürgen ^b   Mikus, Gerd ^b   Walter Sack, Ingeborg ^b   Heiner Schirmer, R ^b   Sié, Ali ^a   Meissner, Peter ^b,e   Müller, Olaf ^b  

^a CENTRE DE RECHERCHE EN SANTÉ DE NOUNA   (Burkina Faso)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY OF ULM   (Germany)

Author keywords

Africa; Burkina Faso; Efficacy; Falciparum malaria; Methylene blue

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; METHYLENE BLUE; UNCLASSIFIED DRUG; UROLENE BLUE;

CHEMICAL COMPOUND; DISEASE TREATMENT; MALARIA; POLYMERASE CHAIN REACTION; PUBLIC HEALTH;

ADULT; ARTICLE; BURKINA FASO; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG TREATMENT FAILURE; DYSURIA; EVENING DOSAGE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MONOTHERAPY; MORNING DOSAGE; OPEN STUDY; PHASE 2 CLINICAL TRIAL; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; ANTIMALARIALS; BURKINA FASO; DRUG ADMINISTRATION SCHEDULE; DYSURIA; ENZYME INHIBITORS; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; METHYLENE BLUE; MIDDLE AGED; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; SINGLE-BLIND METHOD; YOUNG ADULT;

BURKINA FASO; NOUNA;

PLASMODIUM FALCIPARUM;

EID: 77952283076     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2010.02526.x     Document Type: Article

References (16)

1. Buchholz K, Comini MA, Wissenbach D et al. (2008) Cytotoxic interactions of methylene blue with trypanosomatid-specific disulfide reductases and their dithiol products. Molecular & Biochemical Parasitology 160, 65 69.
2. Ferreira C (1893) Sur l′emploi du bleu de méthylène dans la malaria infantile. Revue de Thérapeutique Médico- Chirurgicale 124, 488 525.
3. Greenwood BM, Bojang K, Whitty CJ Targett GA (2005) Malaria. Lancet 365, 1487 1498.
4. International Artemisinin Study Group (2004) Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363, 9 17.
5. Kouyate B, Sie A, Ye M, De AM Müller O (2007) The great failure of malaria control in Africa: a district perspective from Burkina Faso. PLoS Medicine 4, e127.
6. Mandi G, Witte S, Meissner P et al. (2005) Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso. Tropical Medicine and International Health 10, 32 38.
7. Meissner PE, Mandi G, Witte S et al. (2005) Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]. Malaria Journal 4, 45.
8. Meissner PE, Mandi G, Coulibaly B et al. (2006) Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine. Malaria Journal 5, 84.
9. Müller O, Boele vam Hensbroek M, Jaffar S et al. (1996) A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulfadoxine in Gambian children with uncomplicated malaria. Tropical Medicine and International Health 1, 124 132.
10. Müller O, Becher H, van Zweeden AB et al. (2001) Effect of zinc supplementation on malaria and other causes of morbidity in west African children: randomised double blind placebo controlled. BMJ 322, 1567.
11. Schirmer RH, Coulibaly B Stich A (2003) Methylene blue in the treatment of malaria - past and presence. Redox Report 8, 272 276.
12. Snounou G, Zhu X, Siripoon N et al. (1999) Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 369 374.
13. Sokhna CS, Rogier C, Dieye A Trape JF (2000) Host factors affecting the delay of reappearance of Plasmodium falciparum after radical treatment among a semi-immune population exposed to intense perennial transmission. American Journal of Tropical Medicine and Hygiene 62, 266 270.
14. Walter-Sack I, Rengelshausen J, Oberwittler H et al. (2009) High absolute bioavailability of methylene blue given as an aqueous oral formulation. European Journal of Clinical Pharmacology 65, 179 189.
15. WHO (2003) Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. WHOHTMRBM2003.50.
16. Zoungrana A, Coulibaly B, Sie A et al. (2008) Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. PLoS ONE 3, e1630.